HER2 Support Group Forums

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)
-   Clinical Trials (https://her2support.org/vbulletin/forumdisplay.php?f=29)
-   -   ASCO 2013 - Elizabeth A. Mittendorf, M.D., Ph.D., HER2 Peptide (https://her2support.org/vbulletin/showthread.php?t=58695)

'lizbeth 07-28-2013 10:30 AM

ASCO 2013 - Elizabeth A. Mittendorf, M.D., Ph.D., HER2 Peptide

Her2 vaccines are a step closer to getting in Standard of Care.

It will be awesome to have a vaccine to help prevent recurrence. I want to extend a special thanks to fellow Her2Support members who enrolled in vaccine trials.

For the newer board members, the trials are switching from Her2+++ to the lower expressors Her2+ and Her2++. These lower expressors are typically grouped into the "triple negative" category.

Phase II studies might still be open for us, the high expressors.

As we can see the numbers being offered be Dr. Mittendorf are based on the high expressors (us).

Personally I am hoping that the vaccines will eventually be approved for all patients with expressions of Her2, no matter what the level.

As Lani would put it, we want to keep the puppy in by closing the door (stop the growth of cancer by blocking a specific pathway).

All times are GMT -7. The time now is 11:47 AM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2022, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021